The Pharma Data
JULY 29, 2021
BOTOX ® was first approved by the FDA in 1989 for two rare eye muscle disorders – blepharospasm and strabismus in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. About BOTOX ®. Cornea problems have been reported. versus 0.4%, respectively).
The Pharma Data
SEPTEMBER 10, 2021
About BOTOX ® BOTOX ® was first approved by the FDA in 1989 for two rare eye muscle disorders – blepharospasm and strabismus in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. Cornea problems have been reported. versus 0.4%, respectively).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delveinsight
DECEMBER 18, 2020
Brain infection from parasites (malaria, neurocysticercosis), viruses (influenza, dengue, Zika), and bacteria. You should try knowing your triggers to keep a track on it and have a proper response plan made with the help of your doctors. If you have experienced it before, then you can call your doctor to inform him about it.
The Pharma Data
APRIL 1, 2021
FDA approval for adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. Serious infections have happened in some people taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body.
The Pharma Data
SEPTEMBER 8, 2021
About BOTOX ® BOTOX ® was first approved by the FDA in 1989 for two rare eye muscle disorders – blepharospasm and strabismus in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. Atogepant is currently under review by the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content